Novocure Reports Surprise Loss As Revenue Falls Short

Novocure (NVCR) on Thursday reported an adjusted loss of 4 cents a share $134.7 million in sales for its first quarter. In response, NVCR stock fell.


On average, analysts polled by FactSet expected Novocure to report earnings of 2 cents per share and $138.7 million in sales.

In the year-earlier period, Novocure earned 4 cents a share on $101.8 million in sales.

For the year, analysts see Novocure earnings of 17 cents per share and $590 million in sales.

In premarket trading on the stock market today, NVCR stock fell 4% to 196.50. NVCR stock recently broke out of a consolidation with a buy point at 194.85, according to

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Teva Pharma Stock Hits The Skids As Revenue Declines — Again

Novavax Sparks Again As Biden Hints Covid Vaccine Is Nearing Authorization

Looking For The Next Apple Or Amazon? Start With These S&P 500-Beating Lists

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

Watch IBD’s Investing Strategies Show For Actionable Market Insights

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button